Mouritsen S, Høier-Madsen M, Demant E J, Permin H
Acta Pathol Microbiol Immunol Scand C. 1985 Oct;93(5):205-10. doi: 10.1111/j.1699-0463.1985.tb02946.x.
An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of human auto antibodies to mitochondria (AMA). The ELISA was compared to the previous routine method - indirect immunofluorescence technique (IIF)--and optimized for the specific detection of patients with primary biliary cirrhosis. Sera from 72 patients with primary biliary cirrhosis, 10 sera positive for anti-cardiolipin antibodies from patients with syphilis, 9 patients with drug-induced pseudolupus erythematosus, 19 patients with non-alcoholic chronic active hepatitis, 14 patients with systemic lupus erythematosus, 20 patients with rheumatoid arthritis and 100 healthy blood-donors were examined for AMA by both methods. The nosological sensitivity for the ELISA method was comparable to the IIF. The ELISA method was accurate, precise, inexpensive and well-suited as a diagnostic screening method for AMA when primary biliary cirrhosis is suspected. Furthermore, ELISA methods require less experience of the observer than IIF.
已开发出一种酶联免疫吸附测定法(ELISA)用于检测人抗线粒体自身抗体(AMA)。将该ELISA法与之前的常规方法——间接免疫荧光技术(IIF)进行比较,并针对原发性胆汁性肝硬化患者的特异性检测进行了优化。采用这两种方法检测了72例原发性胆汁性肝硬化患者的血清、10例梅毒患者抗心磷脂抗体阳性血清、9例药物性假狼疮患者、19例非酒精性慢性活动性肝炎患者、14例系统性红斑狼疮患者、20例类风湿性关节炎患者以及100名健康献血者的AMA。ELISA法的疾病敏感性与IIF相当。当怀疑有原发性胆汁性肝硬化时,ELISA法准确、精确、成本低廉,非常适合作为AMA的诊断筛查方法。此外,与IIF相比,ELISA法对观察者的经验要求较低。